Synthesis within the body starts with the mevalonate pathway where two molecules of condense to form . This is followed by a second condensation between acetyl CoA and acetoacetyl-CoA to form . This molecule is then reduced to by the enzyme HMG-CoA reductase. Production of mevalonate is the rate-limiting and irreversible step in cholesterol synthesis and is the site of action for statins.
Acetyl-CoA is coming from Citric Acid Cycle.
Mevalonate pathway
Acetoacetyl-CoA thiolase
2 => .
Hydroxymethylglutaryl-CoA synthase or HMG-CoA synthase; EC 2.3.3.10
+ => .
HMG-CoA Reductase
=>
The HMG binding pocket is the site of catalysis in HMGR. (1dqa) is a critical structural element of this binding site. Residues and are positioned in the active site as is . It is this K691 that likely stabilizes the negatively charged oxygen of the first mevaldyl-CoA intermediate.[1] The mevaldyl CoA intermediate is subsequently converted to Mavaldehyde with added stabilization from . It is then believed that the close proximity of increases the pKA of E559, allowing it to be a proton donor for the reduction of mevaldehyde into mevalonate.
Mevalonate kinase
Phosphomevalonate kinase
- The Crystal Structure of Human Phosphomavelonate Kinase At 1.8 A Resolution 3ch4
Mevalonate-5-pyrophosphate decarboxylase
Diphosphomevalonate decarboxylase (EC 4.1.1.33), most commonly referred to in scientific literature as mevalonate diphosphate decarboxylase.
Isopentenyl pyrophosphate isomerase
Isopentenyl pyrophosphate isomerase (EC 5.3.3.2, IPP isomerase), also known as Isopentenyl-diphosphate delta isomerase
Mevalonate is finally converted to isopentenyl pyrophosphate.
Next steps of Cholesterol Biosynthesis
Geranyl transferase
Three molecules of isopentenyl pyrophosphate condense to form farnesyl pyrophosphate through the action of geranyl transferase. Other names in common use include:
- farnesyl-diphosphate synthase
- geranyl transferase I
- prenyltransferase
- farnesyl pyrophosphate synthetase
- farnesylpyrophosphate synthetase
Squalene synthase
Two molecules of farnesyl pyrophosphate then condense to form squalene by the action of squalene synthase in the endoplasmic reticulum.
Oxidosqualene cyclase
Oxidosqualene cyclase then cyclizes squalene to form lanosterol.
Finally, is converted to via either of two pathways, the Bloch pathway, or the Kandutsch-Russell pathway.
